Keyword Analysis & Research: pfizer
Keyword Research: People who searched pfizer also searched
Search Results related to pfizer on Search Engine
-
Pfizer: One of the world's premier biopharmaceutical companies
https://www.pfizer.com/
WebPfizer prioritizes the health and well-being of people and the planet to deliver breakthroughs around the world in a responsible way. Learn more in Pfizer’s 2023 Impact Report Behind the Science Feature
DA: 30 PA: 12 MOZ Rank: 36
-
Pfizer - Wikipedia
https://en.wikipedia.org/wiki/Pfizer
WebPfizer Inc. (/ ˈ f aɪ z ər / FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
DA: 14 PA: 62 MOZ Rank: 54
-
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives …
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-biontech-covid-19-vaccine-comirnatyr-receives-full
WebDec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted approval by the FDA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210823005499/en/ The vaccine has been available in the U.S. under Emergency Use Authorization (EUA) since December 11, …
DA: 43 PA: 26 MOZ Rank: 99
-
Our Products: Holding the Promise of a Breakthrough | Pfizer
https://www.pfizer.com/products/
WebIn this section find an overview of our Pfizer Products and search for information on our most popular Pfizer products. Our products are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.
DA: 99 PA: 30 MOZ Rank: 74
-
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 …
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-omicron-adapted-covid-19
WebSaturday, June 25, 2022 - 10:00am. View pdf copy Copy to clipboard Open in tab. Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increase ...
DA: 17 PA: 1 MOZ Rank: 10
-
FDA Approves First COVID-19 Vaccine | FDA
https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
WebAugust 23, 2021. Español. Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be...
DA: 27 PA: 46 MOZ Rank: 61
-
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-phase-3-trial-data-showing
WebSep 22, 2021 · NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 years of age …
DA: 42 PA: 91 MOZ Rank: 80
-
Pfizer Coronavirus Resources: Covid-19 Updates, News, Information | Pfizer
https://www.pfizer.com/science/coronavirus-resources
WebCoronavirus Resources: COVID-19 Information and Our Scientific Efforts. Our scientific efforts played an important role during a global health crisis. Learn more about SARS-CoV-2, the coronavirus that causes COVID-19 disease, and …
DA: 27 PA: 71 MOZ Rank: 75
-
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 …
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine
WebNov 18, 2020 · NEW YORK & MAINZ, Germany-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study’s primary efficacy endpoints. Analysis of the …
DA: 80 PA: 4 MOZ Rank: 57
-
FDA Approves Pfizer Vaccine: Live Updates - The New York Times
https://www.nytimes.com/live/2021/08/23/world/covid-delta-variant-vaccine
WebAug 23, 2021 · The Food and Drug Administration on Monday granted full approval to Pfizer-BioNTech’s coronavirus vaccine for people 16 and older, making it the first to move beyond emergency-use status in the ...
DA: 41 PA: 15 MOZ Rank: 9